Metabolic Syndrome: Is It a Syndrome? Does It Matter?
Kahn
Circulation 2007;115:1806-1811.
FULL TEXT
The Metabolic Syndrome (Emperor) Wears No Clothes
Kahn
Diabetes Care 2006;29:1693-1696.
FULL TEXT
A Pharmacist Approach to Wellness Maintenance in the Community Elderly
Maher
Journal of Pharmacy Practice 2004;17:133-136.
ABSTRACT
Get With the Guidelines for Cardiovascular Secondary Prevention: Pilot Results
LaBresh et al.
Arch Intern Med 2004;164:203-209.
ABSTRACT
| FULL TEXT
Primary Prevention of Coronary Heart Disease in the Elderly
Dornbrook-Lavender et al.
The Annals of Pharmacotherapy 2003;37:1654-1663.
ABSTRACT
| FULL TEXT
Task force #4--how do we select patients for atherosclerosis imaging?
Wilson et al.
J Am Coll Cardiol 2003;41:1898-1906.
FULL TEXT
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals
Fried et al.
J Am Coll Cardiol 2003;41:1364-1372.
ABSTRACT
| FULL TEXT
References
Circulation 2002;106:3373-3421.
FULL TEXT
Low-Density Lipoprotein, Non-High-Density Lipoprotein, and Apolipoprotein B as Targets of Lipid-Lowering Therapy
Grundy
Circulation 2002;106:2526-2529.
FULL TEXT
Statin Therapy in Older Persons: Pertinent Issues
Grundy
Arch Intern Med 2002;162:1329-1331.
FULL TEXT
Therapy With Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors (Statins) and Associated Risk of Incident Cardiovascular Events in Older Adults: Evidence From the Cardiovascular Health Study
Lemaitre et al.
Arch Intern Med 2002;162:1395-1400.
ABSTRACT
| FULL TEXT
Use of Cholesterol-Lowering Therapy by Elderly Adults After Myocardial Infarction
Ayanian et al.
Arch Intern Med 2002;162:1013-1019.
ABSTRACT
| FULL TEXT
Coronary Artery Calcification in Older Adults to Age 99: Prevalence and Risk Factors
Newman et al.
Circulation 2001;104:2679-2684.
ABSTRACT
| FULL TEXT
Chemopreventive Effects of Cocoa Polyphenols on Chronic Diseases
Weisburger
Exp. Biol. Med. 2001;226:891-897.
ABSTRACT
| FULL TEXT
Improving Coronary Heart Disease Risk Assessment in Asymptomatic People: Role of Traditional Risk Factors and Noninvasive Cardiovascular Tests
Greenland et al.
Circulation 2001;104:1863-1867.
FULL TEXT
Prevention and Treatment of Coronary Heart Disease: Who Benefits?
LaRosa
Circulation 2001;104:1688-1692.
ABSTRACT
| FULL TEXT
Cholesterol lowering in the older population: time for reassessment?
Kagansky et al.
QJM 2001;94:457-463.
ABSTRACT
| FULL TEXT
Use of Lipid-Lowering Medications at Discharge in Patients With Acute Myocardial Infarction : Data From the National Registry of Myocardial Infarction 3
Fonarow et al.
Circulation 2001;103:38-44.
ABSTRACT
| FULL TEXT
Lipid-Lowering Therapy in Patients With Coronary Artery Disease: Sex or Age Bias?
Sgadari et al.
Arch Intern Med 2000;160:2684-2685.
FULL TEXT